Literature DB >> 25382640

Association of hyperuricemia with conventional cardiovascular risk factors in elderly patients.

Teodoro Marotta1, Maria Liccardo, Federico Schettini, Francesco Verde, Aldo L Ferrara.   

Abstract

The relationship between serum uric acid (UA) and cardiovascular risk profile was investigated in 557 outpatients (415 women) aged 60 years and older. Patients were grouped according to a UA cutoff level of 5.5 mg/dL. Prevalence of obesity, hypertension, and impaired glucose metabolism was increased in women with higher UA, who had higher body mass index (37.7±6.9 vs 33.1±5.9 kg/m(2) , P<.001), waist circumference, and serum glucose and triglyceride concentrations than women with lower UA levels. Conversely, men with higher UA levels showed lower high-density lipoprotein cholesterol and higher left ventricular mass than men with lower UA levels. Estimated glomerular filtration rate was reduced in patients with high UA levels of both sexes (65±17 vs 72±16 mL/min/1.73 m(2) , P<.001, for women; 70±16 vs 76±15 mL/min/1.73 m(2) , P<.03, for men). Grouping patients by sex-specific median UA concentrations produced similar results. These data indicate that, even in the elderly, UA clusters in a sex-specific fashion with features of metabolic syndrome and signs of target organ damage. ©2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25382640      PMCID: PMC8031943          DOI: 10.1111/jch.12434

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  41 in total

1.  Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity.

Authors:  L A Ferrara; H Wang; J G Umans; N Franceschini; S Jolly; E T Lee; J Yeh; R B Devereux; B V Howard; G de Simone
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-06-19       Impact factor: 4.222

Review 2.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

3.  Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.

Authors:  B F Culleton; M G Larson; W B Kannel; D Levy
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

4.  Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study.

Authors:  P Verdecchia; G Schillaci; G Reboldi; F Santeusanio; C Porcellati; P Brunetti
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

Review 5.  Is there anything good in uric acid?

Authors:  B Alvarez-Lario; J Macarrón-Vicente
Journal:  QJM       Date:  2011-09-09

6.  Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients.

Authors:  Teodoro Marotta; Barbara F Russo; L Aldo Ferrara
Journal:  Obesity (Silver Spring)       Date:  2009-12-17       Impact factor: 5.002

7.  Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998.

Authors:  Mercedes R Carnethon; Stephen P Fortmann; Latha Palaniappan; Bruce B Duncan; Maria I Schmidt; Lloyd E Chambless
Journal:  Am J Epidemiol       Date:  2003-12-01       Impact factor: 4.897

8.  Hyperuricemia as a risk factor for cardiovascular mortality.

Authors:  A Reunanen; H Takkunen; P Knekt; A Aromaa
Journal:  Acta Med Scand Suppl       Date:  1982

9.  The impact of serum uric acid on cardiovascular outcomes in the LIFE study.

Authors:  Aud Høieggen; Michael H Alderman; Sverre E Kjeldsen; Stevo Julius; Richard B Devereux; Ulf De Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Cong Chen; Björn Dahlöf
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

10.  Effect of insulin on uric acid excretion in humans.

Authors:  A Quiñones Galvan; A Natali; S Baldi; S Frascerra; G Sanna; D Ciociaro; E Ferrannini
Journal:  Am J Physiol       Date:  1995-01
View more
  7 in total

1.  Evaluation of patients diagnosed with essential arterial hypertension through network analysis.

Authors:  L Suciu; C Cristescu; A Topîrceanu; L Udrescu; M Udrescu; V Buda; M C Tomescu
Journal:  Ir J Med Sci       Date:  2015-08-29       Impact factor: 1.568

Review 2.  Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases.

Authors:  Hongsha Wang; Haifeng Zhang; Lin Sun; Weiying Guo
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

3.  Reply to "Association of Serum Uric Acid Concentration With Metabolic Risk Factors in Patients With Type 2 Diabetes".

Authors:  Teodoro Marotta; Maria Liccardo; Federico Schettini; Francesco Verde; Aldo L Ferrara
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-06-02       Impact factor: 3.738

4.  Association of Serum Uric Acid Concentration With Metabolic Risk Factors in Patients With Type 2 Diabetes.

Authors:  Hidekatsu Yanai; Yuji Hirowatari
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-06-02       Impact factor: 3.738

5.  Beauty in Simplicity: Abnormal Neutrophil to Lymphocyte Ratio in Resistant Hypertension.

Authors:  Tibor Fülöp; Mihály Tapolyai
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-23       Impact factor: 3.738

6.  Association between serum uric acid and left ventricular hypertrophy/left ventricular diastolic dysfunction in patients with chronic kidney disease.

Authors:  Il Young Kim; Byung Min Ye; Min Jeong Kim; Seo Rin Kim; Dong Won Lee; Hyo Jin Kim; Harin Rhee; Sang Heon Song; Eun Young Seong; Soo Bong Lee
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

Review 7.  Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review.

Authors:  Usama A A Sharaf El Din; Mona M Salem; Dina O Abdulazim
Journal:  J Adv Res       Date:  2016-12-03       Impact factor: 10.479

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.